access
Takeda secures $38 million grant to develop affordable polio vaccine
May 10, 2016Manufacturing and Production, Research and Development Bill and Melinda Gates Foundation, Gates Foundation, Takeda, Vaccine, access, developing countries, grant, polio
Takeda Pharmaceuticals has received a $38 million grant from the Bill and Melinda Gates Foundation to develop a low-cost polio …
Laying bare the complexities of the pricing issue
November 30, 2015Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, access, affordability, cost of medicines
Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions …
Novartis and Biogen launch drug access programmes in developing countries
October 15, 2015Manufacturing and Production, Sales and Marketing Biogen, Novartis, access, aid, corporate social responsibility, csr, humanitarian aid
Novartis and Biogen have begun new campaigns aimed at increasing access to medicines in developing countries. The Swiss firm has …
GSK tops pharma league for access
November 17, 2014Sales and Marketing Africa, GSK, Novo Nordisk, access, market, vaccines
GlaxoSmithKline is basking in some good news after topping the league table of pharma companies which do the most to …
New market access approach could save poorer countries millions
December 1, 2009Sales and Marketing HIV, access, developing world
An innovative approach to improving access to drugs for HIV/Aids, tuberculosis and malaria could save poorer countries millions of …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
